SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-018674
Filing Date
2023-04-17
Accepted
2023-04-17 16:38:02
Documents
6
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20006698x1_def14a.htm DEF 14A 644598
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 logo_appliedtherapeuticx1.jpg GRAPHIC 28202
4 ny20006698x1-pc_1.jpg GRAPHIC 550063
5 ny20006698x1-pc_2.jpg GRAPHIC 503223
6 sig_shoshanashendelman.jpg GRAPHIC 16900
  Complete submission text file 0001140361-23-018674.txt   2200400
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38898 | Film No.: 23824399
SIC: 2834 Pharmaceutical Preparations